Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oikawa

Showing results (211-220 of 402) with videos related to

Pageof 41
Sort By:
Journal of Biochemistry|September 1, 1986
Synergistic effects of the myc and ras oncogenes on ganglioside synthesis by BALB/c 3T3 fibroblastsM Takimoto, T Hirakawa, T Oikawa, et al.
Experientia|June 15, 1978
Possible presence of autoantibodies to zone pellucida in infertile womenT Mori, T Nishimoto, M Kitagawa, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivationK Yamashina, T Oikawa, M Kasai, et al.
Drugs|January 1, 1988
Effects of antibiotics on platelet aggregationK Sunakawa, H Akita, S Iwata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 12, 2000
[Primary testicular carcinoid tumor: a case report]H Kinsui, T Oikawa, S Hamano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
A case of rapidly progressive glomerulonephritis associated with bucillamine-treated rheumatoid arthritisA Yoshida, K Morozumi, A Takeda, et al.
Experimental Cell Research|April 1, 1989
Reduced DNase I sensitivity of the rearranged c-myc gene in somatic cell hybrids between murine plasmacytoma cells and fibroblastsN Kondoh, T Oikawa, Y Yuhki, et al.
Biochemical and Biophysical Research Communications|December 31, 1991
Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitorT Oikawa, M Hasegawa, M Shimamura, et al.
Leukemia Research|January 1, 1987
Unresponsiveness of both non-rearranged and rearranged c-myc to serum stimulation in a mouse plasmacytoma S194N Kondoh, T Oikawa, I Chiba, et al.
Anti-Cancer Drugs|October 1, 1991
Antitumor effect of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz[a]anthraceneT Oikawa, Y Yoshida, M Shimamura, et al.
Pageof 41

Showing results (211-220 of 402) with videos related to

Sort By:
Pageof 41
Journal of Biochemistry|September 1, 1986
Synergistic effects of the myc and ras oncogenes on ganglioside synthesis by BALB/c 3T3 fibroblastsM Takimoto, T Hirakawa, T Oikawa, et al.
Experientia|June 15, 1978
Possible presence of autoantibodies to zone pellucida in infertile womenT Mori, T Nishimoto, M Kitagawa, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivationK Yamashina, T Oikawa, M Kasai, et al.
Drugs|January 1, 1988
Effects of antibiotics on platelet aggregationK Sunakawa, H Akita, S Iwata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 12, 2000
[Primary testicular carcinoid tumor: a case report]H Kinsui, T Oikawa, S Hamano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
A case of rapidly progressive glomerulonephritis associated with bucillamine-treated rheumatoid arthritisA Yoshida, K Morozumi, A Takeda, et al.
Experimental Cell Research|April 1, 1989
Reduced DNase I sensitivity of the rearranged c-myc gene in somatic cell hybrids between murine plasmacytoma cells and fibroblastsN Kondoh, T Oikawa, Y Yuhki, et al.
Biochemical and Biophysical Research Communications|December 31, 1991
Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitorT Oikawa, M Hasegawa, M Shimamura, et al.
Leukemia Research|January 1, 1987
Unresponsiveness of both non-rearranged and rearranged c-myc to serum stimulation in a mouse plasmacytoma S194N Kondoh, T Oikawa, I Chiba, et al.
Anti-Cancer Drugs|October 1, 1991
Antitumor effect of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz[a]anthraceneT Oikawa, Y Yoshida, M Shimamura, et al.
Pageof 41